Actinium Pharmaceuticals Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.04

+0.08 (+7.90%)

As of Aug 15, 2:27 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 9 82%

Hold 2 18%

Sell 0 0%

Price Target

Analyst Price Target +3,372.1% upside

Low Target $23.47

Average Target $36.11

High Target $39.96

Current Price $1.04

Current
$1.04

Target
$36.11

$23.47 $36.11 avg $39.96

Scenario Analysis

Bear Case

$23.47

2,156.7%

Low target

Base Case

$36.11

+3,372.1%

Avg target

Bull Case

$39.96

+3,742.3%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$1.81

-42.4% from high

52-Week Low

$0.74

+41.5% from low

Target vs 52W High

$36.11

+1,899.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%